The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of gemcitabine-platinum (Gem-P) in patients with advanced gall bladder (GB) cancer: A more aggressive disease compared to the West Tata Memorial Centre (TMC) experience.
Bhawna Sirohi
No relevant relationships to disclose
Vipul Sheth
No relevant relationships to disclose
Ashish Singh
No relevant relationships to disclose
Mukta Ramadvar
No relevant relationships to disclose
Vikas Otswal
No relevant relationships to disclose
Mahesh Goel
No relevant relationships to disclose
Shailesh V. Shrikhande
No relevant relationships to disclose